SJS Investment Consulting
PLSE icon

SJS Investment Consulting’s Pulse Biosciences PLSE Stock Holding History

SJS Investment Consulting’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.45K Buy
49
+17
+53% +$717 ﹤0.01% 2128
2026
Q2 		$888 Buy
+32
New +$755 ﹤0.01% 2068

Other funds holding PLSE

Griffin Asset Management
Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Bender Robert & Associates
Bender Robert & Associates Pasadena, California $525M AUM 38.43% 1-Year Est. Return
Lewis Asset Management
Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

SJS Investment Consulting's PLSE Position: Q3 2026 in Review

SJS Investment Consulting increased its Pulse Biosciences (PLSE) stake by 53% in Q3 2026, buying an estimated $717 and bringing the position to 49 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

SJS Investment Consulting first reported a position in PLSE in Q2 2026 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • SJS Investment Consulting held 49 shares of Pulse Biosciences worth $2.45K as of Q3 2026.
  • SJS Investment Consulting bought 17 Pulse Biosciences shares in Q3 2026, an estimated $717.
  • Pulse Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2128 holding.
  • SJS Investment Consulting first reported a position in Pulse Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.